Table 4.
Comparison of CAINS Scores of the Schizophrenia Group, First-Degree Relative Group and Control Group
| SZ (n = 44) | REL (n = 43) | HC (n = 44) | F/χ2 | Bonferroni | ||||
|---|---|---|---|---|---|---|---|---|
| M | SD | M | SD | M | SD | |||
| Age | 53.75 | 8.23 | 56.33 | 9.73 | 54.54 | 13.22 | 0.67 | |
| Gender (male/female) | 24/20 | 18/25 | 14/30 | 4.66 | ||||
| Education | 11.51 | 2.47 | 11.24 | 3.83 | 11.55 | 3.04 | 0.12 | |
| Medicationa | 290.96 | 199.92 | ||||||
| Duration of illness | 20.08 | 9.85 | ||||||
| PANSS | ||||||||
| Negative symptoms | 14.24 | 6.44 | ||||||
| Positive symptoms | 10.24 | 4.03 | ||||||
| General psychopathology | 24.35 | 6.81 | ||||||
| SANS_total | 23.28 | 21.85 | ||||||
| CAINS_motivation/pleasure | 18.77 | 6.73 | 9.93 | 5.57 | 2.93 | 2.59 | 100.16*** | SZ > REL > HC |
| CAINS_expression | 5.09 | 4.40 | 0.53 | 0.83 | 0.20 | 0.80 | 47.18*** | SZ > REL, HC |
Note: SZ, schizophrenia; REL, first-degree relatives of people with schizophrenia; HC, healthy controls.
aChlorpromazine equivalence, mg/day.
***P < .001.